“…[3] Benzimidazole scaffold is present in various pharmacologically active molecules such as bendamustine, omeprazole, telmisartan, lansoprazole, rabeprazole, pantoprazole, mebendazole, albendazole, pimobendam, triclabendazole, and nocodazole ( Figure 1). [4,5] In this view, the incorporation of benzoyl group into benzimidazole can enhance their lipophilicity, bioavailability, and thereby increase the biological potency. [6] Benzimidazole derivatives comprise a auspicious group of heterocyclic derivatives having a large number of pharmaceutical activities such as antimicrobial, [7][8][9][10] antiprotozoal, [11] anthelmintic, [12][13][14] anticancer, [15][16][17] anti-HIV, [18] anticonvulsant, [19] anti-inflammatory, [20] antineoplastic, [21] antiulcer, [22] antiviral, [23][24][25] antihypertensive, [26,27] antitubercular, [28,29] antiulcer activity, [30] anti-histaminic [31] and anti-oxidant.…”